These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23421108)

  • 1. [The etiology of Graves' disease--current state of knowledge].
    Hen K; Czarnywojtek A; Florek E; Warmuz-Stangierska I; Ruchała M
    Przegl Lek; 2012; 69(10):1132-4. PubMed ID: 23421108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
    Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
    J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and discrimination of autoimmune Graves' disease and Hashimoto's disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes.
    Fukushima H; Matsuo H; Imamura K; Morino K; Okumura K; Tsumoto K; Yoshimura T
    J Biosci Bioeng; 2009 Dec; 108(6):551-6. PubMed ID: 19914592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune thyrotoxicosis: diagnostic challenges.
    Ponto KA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1. PubMed ID: 22938935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor autoantibodies in Graves' disease.
    Schott M; Scherbaum WA; Morgenthaler NG
    Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
    Minich WB; Weymayer JD; Loos U
    Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' animal models of Graves' hyperthyroidism.
    Nagayama Y
    Thyroid; 2007 Oct; 17(10):981-8. PubMed ID: 17822377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
    Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells in Graves' disease.
    Purnamasari D; Soewondo P; Djauzi S
    Acta Med Indones; 2015 Jan; 47(1):61-9. PubMed ID: 25948770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
    Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
    J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
    Minich WB; Loos U
    Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
    Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.